NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: Involvement in cancer progressiveness

被引:36
作者
Morimoto, Kazuya [1 ]
Tanaka, Tomoaki [1 ]
Nitta, Yujiro [1 ]
Ohnishi, Keiko [1 ]
Kawashima, Hidenori [1 ]
Nakatani, Tatsuya [1 ]
机构
[1] Osaka City Univ, Dept Urol, Grad Sch Med, Osaka 5450051, Japan
关键词
prostate cancer; TGF-beta; epithelial-mesenchymal transition; NEDD9; ADENOCARCINOMA CELLS; PROTEIN HEF1; METASTASIS; PROMOTES; GROWTH; PHOSPHORYLATION; P130(CAS); ADHESION; CYCLE; MICRORNA-145;
D O I
10.1002/pros.22809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND NEDD9 is one of the Crk-associated substrate (Cas) family proteins that mediate downstream signaling processes including cytoskeletal organization, cell-cycle and tumorigenesis. While NEDD9 plays a crucial role in epithelial-mesenchymal transition (EMT), the functional mechanism underlying NEDD9-mediated EMT in prostate cancer (PCa) remains uncertain. METHODS The expression levels of NEDD9 and its downstream molecules in PC-3, LNCaP, and VCaP cells exposed to transforming growth factor-beta (TGF-beta) were determined by western blotting. The invasion of these cells with ectopic overexpression of NEDD9 or silencing of NEDD9 expression was measured by transwell invasion assay. Human tissue samples comprising 45 PCa specimens and ten specimens of normal prostatic tissue were used for immunohistochemical (IHC) analysis of NEDD9 expression. RESULTS Both NEDD9 and its downstream signaling molecules associated with EMT were strongly induced by TGF-beta in PCa cells. PC-3 cells with stable overexpression of NEDD9 had a mesenchymal phenotype and significantly enhanced cell invasion, despite their decreased cell proliferation. Knockdown of endogenous NEDD9 expression completely diminished TGF-beta-triggered tumor invasion in several PCa cell lines. The IHC data revealed a significant positive correlation between the NEDD9 staining score and tumor aggressiveness (e.g., Gleason grade, serum PSA level). The NEDD9 staining score in primary PCa with bone metastasis was significantly higher than that in PCa without metastasis. CONCLUSIONS NEDD9 may be a key mediator involved in TGF-beta-mediated EMT and cell motility in PCa cells and a novel target in the treatment of metastatic PCa and prevention of spread of localized PCa cells to other organs. Prostate 74:901-910, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:901 / 910
页数:10
相关论文
共 44 条
[31]   The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome [J].
Pugacheva, EN ;
Golemis, EA .
NATURE CELL BIOLOGY, 2005, 7 (10) :937-U18
[32]   End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice [J].
Scher, Howard I. ;
Morris, Michael J. ;
Basch, Ethan ;
Heller, Glenn .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27) :3695-3704
[33]  
Speranza MC, 2012, ONCOTARGET, V3, P724
[34]   Epithelial-Mesenchymal Transitions in Development and Disease [J].
Thiery, Jean Paul ;
Acloque, Herve ;
Huang, Ruby Y. J. ;
Angela Nieto, M. .
CELL, 2009, 139 (05) :871-890
[35]   EMT and MET in carcinoma - clinical observations, regulatory pathways and new models [J].
Thompson, Erik W. ;
Williams, Elizabeth D. .
CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (06) :591-592
[36]   Epithelial plasticity, cancer stem cells and bone metastasis formation [J].
van der Pluijm, Gabri .
BONE, 2011, 48 (01) :37-43
[37]   miR-145 inhibits breast cancer cell growth through RTKN [J].
Wang, Shihua ;
Bian, Chunjing ;
Yang, Zhuo ;
Bo, Ye ;
Li, Jing ;
Zeng, Lifen ;
Zhou, Hong ;
Zhao, Robert Chunhua .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (05) :1461-1466
[38]   Anchorage-independent phosphorylation of p130Cas protects lung adenocarcinoma cells from anoikis [J].
Wei, L ;
Yang, Y ;
Zhang, X ;
Yu, Q .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 87 (04) :439-449
[39]   p130Cas Is Required for Mammary Tumor Growth and Transforming Growth Factor-β-mediated Metastasis through Regulation of Smad2/3 Activity [J].
Wendt, Michael K. ;
Smith, Jason A. ;
Schiemann, William P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (49) :34145-34156
[40]  
Wikström P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO